全文获取类型
收费全文 | 3569篇 |
免费 | 162篇 |
国内免费 | 11篇 |
专业分类
耳鼻咽喉 | 14篇 |
儿科学 | 144篇 |
妇产科学 | 40篇 |
基础医学 | 408篇 |
口腔科学 | 57篇 |
临床医学 | 305篇 |
内科学 | 748篇 |
皮肤病学 | 45篇 |
神经病学 | 189篇 |
特种医学 | 143篇 |
外科学 | 401篇 |
综合类 | 45篇 |
一般理论 | 2篇 |
预防医学 | 386篇 |
眼科学 | 151篇 |
药学 | 430篇 |
中国医学 | 6篇 |
肿瘤学 | 228篇 |
出版年
2024年 | 19篇 |
2023年 | 22篇 |
2022年 | 61篇 |
2021年 | 118篇 |
2020年 | 61篇 |
2019年 | 89篇 |
2018年 | 100篇 |
2017年 | 58篇 |
2016年 | 85篇 |
2015年 | 76篇 |
2014年 | 143篇 |
2013年 | 201篇 |
2012年 | 283篇 |
2011年 | 274篇 |
2010年 | 151篇 |
2009年 | 125篇 |
2008年 | 189篇 |
2007年 | 167篇 |
2006年 | 169篇 |
2005年 | 158篇 |
2004年 | 149篇 |
2003年 | 119篇 |
2002年 | 123篇 |
2001年 | 56篇 |
2000年 | 52篇 |
1999年 | 42篇 |
1998年 | 19篇 |
1997年 | 16篇 |
1996年 | 12篇 |
1993年 | 12篇 |
1992年 | 30篇 |
1991年 | 35篇 |
1990年 | 30篇 |
1989年 | 31篇 |
1988年 | 23篇 |
1987年 | 23篇 |
1986年 | 35篇 |
1985年 | 29篇 |
1984年 | 27篇 |
1983年 | 30篇 |
1982年 | 24篇 |
1981年 | 22篇 |
1980年 | 12篇 |
1979年 | 25篇 |
1978年 | 27篇 |
1977年 | 23篇 |
1976年 | 29篇 |
1975年 | 19篇 |
1974年 | 19篇 |
1972年 | 11篇 |
排序方式: 共有3742条查询结果,搜索用时 15 毫秒
81.
82.
83.
Miriam C. Boesch Oliver Wendt Anu Subramanian Ning Hsu 《Research in autism spectrum disorders》2013,7(3):480-493
An experimental, single-subject research study investigated the comparative efficacy of the Picture Exchange Communication System (PECS) versus a speech-generating device (SGD) in developing requesting skills for three elementary-age children with severe autism and little to no functional speech. Results demonstrated increases in requesting behavior for all participants across intervention phases with both augmentative and alternative communication (AAC) intervention strategies; however, difficulties were observed with picture discrimination. The Wilcoxon signed pair test did not reveal significant differences between PECS and the SGD for any participant. Findings suggest PECS and SGD are equally appropriate for developing initial requesting skills. Based on the current findings, successful implementation of either AAC strategy is achievable when appropriate instructional strategies are used. 相似文献
84.
Roma A. Vasa Luther Kalb Micah Mazurek Stephen Kanne Brian Freedman Amy Keefer Traci Clemons Donna Murray 《Research in autism spectrum disorders》2013,7(11):1358-1369
Age-related differences in the prevalence and correlates of anxiety were cross-sectionally examined in 1316 children and adolescents with autism spectrum disorder (ASD) who presented for initial evaluation at 14 outpatient autism centers around the country and in Canada. The prevalence of clinical and subclinical anxiety as well as the correlates of anxiety were examined in three age groups of children: preschool, school age and adolescents. Findings showed that the prevalence of anxiety in each age group exceeded the prevalence of anxiety in the general population. Adolescents and school age children had the highest prevalence of clinical (40%) and subclinical anxiety (26%), respectively. Higher IQ and less ASD severity were each weakly correlated with more anxiety in preschool and school age children. Affective symptoms were strongly associated with anxiety in each age group. Age specific psychiatric comorbidities were also present. Anxiety was associated with attention deficit hyperactivity disorder (ADHD) and oppositional defiant disorder (ODD) symptoms in the preschool group, ODD and somatic symptoms in the school age children, and ADHD symptoms in adolescents. These data underscore the need for prevention and treatment of anxiety as well as research examining the characteristics of anxiety in children with ASD using a developmental framework. 相似文献
85.
Biologic disease modifying anti-rheumatic drugs (DMARD) have revolutionized the management of several rheumatic disorders, especially those with autoimmune inflammatory etiology. A decade of experience has further endorsed their efficacy and unraveled safety issues. Treat to target remission is the current mantra. Infections remain the single most important complication. However, the access to biologics has been severely restricted by their exorbitant cost. Several biologics will lose their patent in the imminent future. An exact replica of a protein molecule is difficult if not impossible. Molecules seemingly similar to biologics called biosimilars or ‘follow on biologics’ are likely to flood the markets world wide at a challenging and affordable price. However, the acceptability of biosimilars will be driven by several contentious issues connected with manufacture, standardization, extent of validation (compared to source innovator biologic), interchangeability (with biologic), regulatory issues, and other patient centric socioeconomic issues. India is likely to provide a fertile field for biosimilar drugs and patients stand to gain from an expanded access and newer treatment paradigms. The fierce competition between several pharmaceutical companies (Indian and multinationals) to gain supremacy will fuel better affordability, equity and access to medicine while upholding the science of quality drugs. The stage is now set for this next big revolution in therapeutics. 相似文献
86.
87.
88.
89.
Subramanian G Quek SY 《Journal of the American Dental Association (1939)》2012,143(7):739-40; author reply 740-1
90.
Veedamali S. Subramanian Svetlana M. Nabokina Hamid M. Said 《Digestive diseases and sciences》2014,59(3):583-590